Edinburgh PhD: Endospore-Derived Protein Lattices for Antigen and Enzyme Display

Edinburgh PhD: Endospore-Derived Protein Lattices for Antigen and Enzyme Display

Research question and applicant decision

This is an Edinburgh four-year protein-materials and biotechnology doctorate, asking whether endospore-derived protein lattices can retain useful display functions while avoiding manufacturing problems associated with whole spores. It is not evidence of an approved vaccine or guaranteed product. The 2027 delegated directory identifies project 200214 and David Radford, Graeme Cowan and Prerna Vohra. Funding is competitive; EastBio accepts international applicants. EastBio waives the international tuition top-up for successful international EastBio awardees and excludes visa/IHS costs; EDC international eligibility, allocation, tuition top-up and visa/IHS terms are unknown. The most important interview questions concern daily supervisory responsibility, access to structural/functional analysis and how a bounded thesis will be assessed. Current official recruitment route; International award conditions

Research Question and Doctoral Work

The advert contrasts the usefulness of naturally organised protein lattices with a translational drawback: whole spores can be difficult to manage in manufacturing facilities. It proposes investigating the protein-material component and comparing products from different research/production backgrounds. The applicant-level question is whether structural organisation and intended display function remain interpretable and consistent across those contexts. Surface presentation, enzyme function, immune response, manufacturing acceptability and human clinical protection are distinct outcomes; none proves all the others.

The doctoral work is described through molecular biology, microbiology and protein biochemistry, with attention to lattice components, structure and display function. The advert's broader ambition is a reusable protein-material platform. It does not publish a final product specification, a clinical trial or an industrial partner agreement. Applicants should clarify the balance between protein-material characterisation, comparative analysis and interpretation of functional evidence, plus the analytical support available. The laboratory must define permitted materials, work responsibilities and training.

The source's claims about historical spore-vaccine candidates and structural studies are scientific background, not proof that this exact proposed platform is validated. The particular recent structural paper behind the recruitment premise has not been identified in the available materials. Ask for the relevant primary references and preliminary evidence. This gap does not make the opportunity academically low-value; it limits what can be concluded about immediate feasibility and the student's independent thesis contribution.

The field's attraction is the connection between protein structure, function and manufacturability. Its challenge is that an attractive material property may bring practical trade-offs, and laboratory observations may not predict product consistency, regulatory acceptability or clinical outcomes. School structural/protein-analysis resources make the environment plausible, not guaranteed. Relevant institutional resources

School, Discipline and Training

The degree university is University of Edinburgh, United Kingdom, with School of Biological Sciences as the academic home. The delegated project listing places the project in Institute of Quantitative Biology, Biochemistry and Biotechnology (IQB3). Some named supervisors' portfolios are associated with Institute of Immunology and Infection Research; these are institutes within one School, not joint-degree partners. Confirm the day-to-day work location and host group rather than borrowing another project's institute. Institute organisational context

The specified registration is Biological Sciences (with Internship) PhD, 48 months full-time, starting 1 October 2027. It is a research doctorate, not a clinical qualification. The first year is probationary, with a thesis committee and annual progression review. Students submit 10-week and 10-month reports, make an oral presentation at the latter, then a year 2 poster and year 3 research talk, followed by a thesis of up to 100,000 words and viva. These are programme milestones, not guaranteed platform outcomes; individual training must reflect this research question. Normal entry is a relevant UK 2:1 or international equivalent with research understanding; EastBio does not generally require a master's. Exact 2027 programme; Partnership eligibility

The School's REF 2021 account reports 94% world-leading/internationally excellent research and 100% world-leading environment, with a UK-top-five subject claim from that exercise. These are dated national subject metrics, not a 2027 global rank or a rating of the three supervisors. Cohort methods, research, professional and thematic training provide breadth alongside the thesis. Subject assessment and date; Training framework

The advert includes a three-month placement. The programme explains a PIPS normally up to three months, with extension up to six months requiring approval. This advert is not labelled CASE and names no industrial partner; do not import the 3–18-month Dyneval CASE arrangement from another project. Placement host, scope, expenses and timing should be agreed through this programme. Programme placement conditions

Supervision, Recent Papers and Resources

University profiles identify David Radford as University Teacher, Graeme Cowan as Senior Lecturer, and Prerna Vohra as Lecturer in Microbiology. These actual titles should be preserved. Radford is named in the advertisement, but a recent 3–5-year primary-publication trajectory was not established from his available profile; do not fill this gap with the work of an unrelated same-name researcher or assume a professor's role. Ask who is the formal lead, who provides daily protein/material expertise and who has responsibility for progression. Radford current role; Cowan current role; Vohra current role

Cowan's portfolio provides antibody/immune-repertoire interpretation, and Vohra's provides microbiology and vaccine-related context. These collaborations do not prove a specific platform result, current student capacity or availability of every method.

The following are three distinct recent original studies involving the named supervisory team, not three validations of the proposed protein lattice platform. Each entry states the material reviewed and any full-text access limitation. Radford’s recent original-publication trajectory and the direct structural references behind this specific project remain gaps.

1. Deep sequencing of BCR heavy chain repertoires in myalgic encephalomyelitis/chronic fatigue syndrome

Audrey A. Ryback; Graeme J. M. Cowan. Frontiers in Immunology 16: 1489312. DOI: 10.3389/fimmu.2025.1489312. Published 2025-02-17; no separate online/issue-day distinction is established beyond this record.

The original Brief Research Report compares 25 mild/moderate and 36 severe ME/CFS participants with 21 healthy and 28 multiple-sclerosis controls. Broad proposed repertoire signatures were largely absent; an exploratory difference needs replication and partly loses significance after correction. This supports disciplined interpretation of negative findings, not a diagnostic test, intervention or proof of lattice protection. Cowan is 2/2; Ryback is corresponding. Evidence reviewed: abstract/metadata and selected results/discussion, including the publisher bibliography and author list; the complete HTML text was not reviewed. Primary record.

2. Structural epitope profiling identifies antibodies associated with critical COVID-19 and long COVID

Patrick Kearns; Charles Dixon; Mihaly Badonyi; Kim Lee; Rafal Czapiewski; Olivia Fleming; Prajitha Nadukkandy; Lukas Gerasimivicous; Rinal Sahputra; Bethany Potts; Sam Benton; Jacky Guy; Scott Neilson; Helen Wise; Sara Jenks; Kate Templeton; CIRCO; Christina Dold; Teresa Lambe; Andrew Pollard; Alexander J Mentzer; Julian C Knight; COMBAT; Susanna Dunachie; Paul Klenerman; Eleanor Barnes; Alan Carson; Laura Mcwhirter; Tracy Hussell; Rennos Fragkoudis; Susan J Rosser; David Cavanagh; Graeme J.M. Cowan; Madhvi Menon; Joseph A. Marsh; Dirk A. Kleinjan; Nick Gilbert. eLife 13: RP98840. DOI: 10.7554/eLife.98840.1. Published 2024-09-02; no separate online/issue-day distinction is established beyond this record.

This is an original Reviewed Preprint version 1, not a verified final Version of Record. The institutional 37 ordered author entities include CIRCO and COMBAT; Cowan is 33/37, and the record marks Kearns/Gilbert corresponding. The as-listed Lukas spelling differs across records and remains provisional because the formal manuscript byline was inaccessible. Antibody-profile associations with clinical heterogeneity establish neither causality/protection nor a validated new-cohort biomarker, and are not a lattice-platform trial. Evidence reviewed: institutional full bibliography and abstract; the publisher Reviewed Preprint and accepted-manuscript PDFs were inaccessible, so full text was not available. Primary record.

3. The advantage of intergenic regions as genomic features for machine-learning-based host attribution of Salmonella Typhimurium from the USA

Antonia Chalka; Tim J. Dallman; Prerna Vohra; Mark P. Stevens; David L. Gally. Microbial Genomics 9(10): 001116. DOI: 10.1099/mgen.0.001116. Published 2023-10-16; no separate online/issue-day distinction is established beyond this record.

This published original observational/computational study concerns attribution from existing data. Prediction becomes unreliable for phylogenetically distinct samples, so within-dataset performance is not a universal biological explanation. Vohra is 3/5 and the institution identifies Gally as corresponding. It is adjacent analytical expertise, not a causal host-range or protein-lattice result; no features, targets or engineering designs are recommended. Evidence reviewed: institutional title, ordered authors, complete citation and abstract; publisher access was unavailable, so full text was not reviewed. Primary record.

The School lists Protein Production, Structural Biology, Light Microscopy, Flow Cytometry and EdinOmics services. They support a plausible research environment for protein/material evidence, but their existence does not establish personal access, training dates, operator support, budget or permissions. The advert does not guarantee cryo-EM, clinical samples, animal work or a computational track. Ask which specific analysis is already supported and how work beyond initial competence is supervised. Actual shared facilities

Funding and International Costs

The project Funding Notes describe a four-year fully funded competition for either an EastBio BBSRC Doctoral Landscape Award or Edinburgh Doctoral College Award (EDC), with a UKRI-rate stipend, tuition cover and project-cost support; no separate EDC application is required. Successful students join the cohort as EastBio-funded or associate-funded researchers. This is an opportunity to compete, not a scholarship already attached to each applicant. EastBio's FAQ says international applicants are eligible and no more than 30% of annual EastBio-network awards may go to international students. This is a network quota, not individual success probability or a UKRI-wide rule; EDC's international eligibility and allocation terms are unknown. Successful international EastBio awardees have the international tuition top-up waived, and EastBio rules exclude visa and health-surcharge costs. EDC international tuition top-up, visa and IHS coverage are unknown. Confirm the terms of whichever award is offered. International fee-waiver boundary; Current School funding routes

The School describes EDC support as tuition plus a four-year stipend and project grant £5,000 in years 1–3 and £1,000 in year 4: £16,000 total research support, not extra living income. UKRI's confirmed 2026/27 minimum is £21,805 stipend and £5,238 Home-fee contribution; the 2027/28 rate is not yet given there. Do not substitute another university's estimated 2027 stipend or fourth-year research budget. EDC grant scope; Confirmed current UKRI reference

The university estimates 2026/27 living costs £18,504/year or £1,542/month, calculated March 2026: accommodation/utilities £978, food/shopping £248, mobile £12, social/leisure/wellbeing £246, bus (age 22+) £58 monthly. Accommodation/utilities illustrations range £752–£1,249/month; the lower private figure is based on a room-share calculation, not a private whole-flat quote or guaranteed place. The 2027/28 stipend and actual housing costs are not yet confirmed. No disposable-income balance or savings projection is calculated from these older reference figures. Current budget methodology

At October 2026 rates, the Student visa application fee is £558, and student IHS is £776/year with partial-year charging rules. If chargeable permission were 4.5 years, the IHS example would be £3,492, or £4,050 with the application fee; actual CAS/permission duration and future rates determine the bill.

The outside-London visa maintenance figure £1,171/month for up to 9 months (£10,539) is a regulatory evidence threshold, not a full-year Edinburgh budget. Sponsorship/CAS and Chinese differential-evidence arrangements require individual checking. Travel, deposits and cash before the first stipend remain separate. Visa fee; IHS rules; Maintenance evidence

Background, Language and Application

The exact advert gives the method domains but does not publish a project-specific list of mandatory prior techniques or a mathematics requirement. Mathematics is not specified as an additional essential condition; the method domains do not mean every technique must already be mastered. Relevant preparation can include protein biochemistry, structural/material analysis, microbiology, immunology and critical quantitative interpretation, but these are suggested preparation areas, not invented admissions prerequisites. Programme entry normally requires a relevant UK 2:1/international equivalent and understanding of research. Programme entry criteria

The 2027 English requirements include IELTS 6.5 overall, each 6.0, without One Skill Retake. TOEFL before 21 January 2026 requires 92 overall/23 each; from that date the new scale requires 4.5 overall/4.5 each, without MyBest aggregation. IELTS/TOEFL must be no more than two years old on 1 October 2027. An English-taught degree must satisfy approved country/institution rules and normally be no more than five years old for non-majority-English-country nationals; a Chinese English-medium degree is not automatically sufficient. Check other accepted qualifications on the actual programme page. International records not in English require originals plus official translations. Applicants can initially apply before taking an English test, but must meet final offer requirements. A student visa requires full-time registration and living within commuting distance; individual ATAS/immigration conditions require confirmation. Exact English criteria; International document/study rules

Only one EastBio project across all hosts may be chosen. Contact the supervisors and prepare the 2027 EastBio form, academic transcripts, anonymous EDI survey response ID, and two references on the official form, from academic/professional referees outside the supervisory team. The FAQ says unsolicited extra documents such as CVs will be disregarded. The programme charges no application fee. Required application process; Materials and referee rules

Apply through Euclid for Biological Sciences with Internship, 1 October 2027; enter the project title, proposed supervisors and funding source, and upload the completed EastBio form in the Research Proposal section. This upload label does not require a separate experimental proposal. The project deadline is midday Monday 16 November 2026, with no explicit portal timezone. Its instructions accept references up to two weeks afterwards, whereas central guidance requests them by 16 November and warns missing references affect shortlisting: seek written host confirmation and aim to complete both by the main deadline. The project says applications remain under consideration until 22 February 2027 and missing material may be requested through Euclid; check portal/email. Scholarships can be amended or withdrawn. Central timetable lists 18 January nominations, 22 February interview invitations, week beginning 8 March interviews and week beginning 22 March decisions, not guaranteed interview/award dates for every applicant. Selection stages

Career directions

The transferable skills are critical comparison, quantitative interpretation, protein/structural science and teamwork. UK National Careers Service describes the broad biochemistry occupation at £28,000 starter–£53,000 experienced; this is not this programme’s salary, placement record or assurance of a biotechnology job. Career evidence scope

Stage-Specific Questions and Next Actions

Before applying: confirm current project availability through the official route, clarify the relevant academic background and choose the single project. Resolve reference timing and documentation/English conditions.

At interview: ask for the direct structural references and preliminary evidence underlying the advert; what fundamental question and independent thesis contribution remain viable if platform translation is unsuccessful? Establish named lead/daily supervisors and the role of Radford's teaching appointment in this supervision structure. Ask about current capacity, training, analytical support, permissions and the balance of work, without assuming specific material access or clinical responsibilities. Clarify the ordinary placement rather than assuming CASE status or a named company.

Before accepting: obtain the exact award, 2027 stipend, full international fee treatment, research/placement expense rules, funded period and any completion support. Check the supervision/committee agreement, CAS/ATAS, upfront visa/IHS costs, housing and arrival cash. No current evidence establishes a commercial product, clinical efficacy, personal facility allocation or a guaranteed job. Resolve these conditions before accepting the appointment.

Evidence and Sources

Paper-specific evidence scopes and full-text access limitations are stated in the relevant entries. The existing materials do not confirm current acceptance, platform feasibility, individual resources or award terms.

Project, school and training

• EASTBIO current official application and delegated project directory
• EASTBIO selection and timeline
• EASTBIO training structure
• Edinburgh Biological Sciences REF 2021 subject context
• Biological Sciences with Internship current 2027 programme
• School research institutes and training structure
• School facilities relevant to protein/structure analysis
• Observed exact university project target; body inaccessible

Supervisors, papers and facilities

• David Radford current official institutional role
• Graeme Cowan current official profile and papers
• Prerna Vohra current official profile and papers
• Ryback and Cowan 2025 immune-repertoire primary research
• Kearns et al. 2024 antibody profiling primary study
• Chalka et al. 2023 microbial host-attribution primary study

Funding, living costs and careers

• EASTBIO current eligibility and overseas fee waiver
• SBS 2027 current EASTBIO and EDC funding
• Edinburgh postgraduate living costs 2026/27
• UKRI current stipend and fee minima
• UK Student visa current application fee
• UK student health surcharge
• UK outside-London maintenance evidence
• National Careers Service biological scientist careers